Statements (17)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:ATC_code
|
gptkbp:ATCCode |
gptkb:N04B
|
gptkbp:class |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
gptkbp:excludes |
anticholinergic agents
|
https://www.w3.org/2000/01/rdf-schema#label |
N04B (Dopaminergic agents)
|
gptkbp:includes |
gptkb:Levodopa
MAO-B inhibitors Dopamine agonists COMT inhibitors |
gptkbp:partOf |
gptkb:N04_(Anti-Parkinson_drugs)
|
gptkbp:regulates |
dopaminergic neurotransmission
|
gptkbp:routeOfAdministration |
oral
parenteral |
gptkbp:treatment |
motor symptoms of Parkinson's disease
|
gptkbp:usedFor |
gptkb:Parkinson's_disease
|
gptkbp:bfsParent |
gptkb:N04BB
|
gptkbp:bfsLayer |
8
|